Incyte Corp (INCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 808,673 | 926,700 | 823,303 | 911,397 | 733,235 |
| Cost of Goods | 56,822 | 59,163 | 54,584 | 50,636 | 42,614 |
| Gross Profit | 751,851 | 867,537 | 768,719 | 860,761 | 690,621 |
| Operating Expenses | 727,903 | 797,607 | 630,927 | 606,966 | 574,695 |
| Operating Income | 24,770 | 70,093 | 138,376 | 254,431 | 116,540 |
| Interest Expense | 469 | 667 | 641 | 678 | 680 |
| Other Income | 27,555 | 11,189 | 10,853 | -24,375 | -45,325 |
| Pre-tax Income | 51,856 | 80,615 | 148,588 | 229,378 | 70,535 |
| Income Tax | 30,153 | 52,154 | 35,813 | 67,946 | 32,543 |
| Net Income Continuous | 21,703 | 28,461 | 112,775 | 161,432 | 37,992 |
| Net Income | $21,703 | $28,461 | $112,775 | $161,432 | $37,992 |
| EPS Basic Total Ops | 0.10 | 0.12 | 0.51 | 0.73 | 0.17 |
| EPS Basic Continuous Ops | 0.10 | 0.13 | 0.51 | 0.73 | 0.17 |
| EPS Diluted Total Ops | 0.10 | 0.13 | 0.50 | 0.72 | 0.17 |
| EPS Diluted Continuous Ops | 0.10 | 0.13 | 0.50 | 0.72 | 0.17 |
| EPS Diluted Before Non-Recurring Items | 0.18 | 0.44 | 0.44 | N/A | N/A |
| EBITDA(a) | $43,981 | $88,311 | $155,068 | $270,938 | $132,978 |